Source: International Congress 2018 – Genetics in chronic pulmonary diseases
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
B. Nikonenko (Moscow, Russian Federation), N. Logunova (Moscow, Russian Federation), I. Bocharova (Moscow, Russian Federation), A. Apt (Moscow, Russian Federation). New inbred mouse strains for the studying M. tuberculosis – host interactions. 4227

Member's Comments

No comment yet.

Related content which might interest you: Induction of M. tuberculosis (MTB) drug resistance (DR) mutations in HIV-infected hosts and pathways of further spread of the evolutionary successful drug-resistant MTB clonal lines Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020 New in vitro model of Mycobacterium tuberculosis dormancy Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection Year: 2020 Analysis of mutations in multiple-drug-resistant M. tuberculosis strains isolated in Kyrgyzstan Source: Eur Respir J 2006; 28: Suppl. 50, 380s Year: 2006 DNA fingerprint analysis of Mycobacterium tuberculosis complex strains isolated from homeless tuberculosis patients in Budapest Source: Eur Respir J 2004; 24: Suppl. 48, 424s Year: 2004 Differentiation of M. bovis BCG from other strains of M. tuberculosis complex by multiplex PCR assay Source: Eur Respir J 2006; 28: Suppl. 50, 170s Year: 2006 Genetic diversity of M. tuberculosis isolates from patients with drug-resistant TB in Japan Source: International Congress 2018 – Current practices in and attitudes to screening for tuberculosis, and a discussion about genetic diversity Year: 2018 Totally drug-resistant tuberculosis strains: evidence of adaptation at the cellular level Source: Eur Respir J 2009; 34: 1202-1203 Year: 2009 Characterization of murine model of chronic M. abscessus respiratory infection. Source: International Congress 2018 – Mechanisms of respiratory infection Year: 2018 On the nature of Mycobacterium tuberculosis-latent bacilli Source: Eur Respir J 2004; 24: 1044-1051 Year: 2004 Estimation of susceptibility hospital strains of Mycobacterium tuberculosis (Mtb) Beijing to disinfectants Source: International Congress 2017 – Paediatric TB: MDRTB (II) Year: 2017 Importance of identifying Mycobacterium bovis as a causative agent of human tuberculosis Source: Eur Respir J 2010; 35: 692-694 Year: 2010 Can M. smegmatis be used as a real alternative for M. tuberculosis? Source: International Congress 2016 – Microbiology: bronchoalveolar lavage (BAL) and PCR Year: 2016 Different genetics background of patients with latent tuberculosis infection versus active tuberculosis Source: International Congress 2017 – Asthma genetics and genomics in patients and populations Year: 2017 Molecular characterization of M. tuberculosis complex strains from a drug resistance survey in Albania Source: Annual Congress 2013 –Tuberculosis: clinical epidemiology and public health Year: 2013 Characteristics of mycobacterial strains isolated from immunocompetent and immunosuppressed patients with particular forms of tuberculosis Source: Annual Congress 2007 - Research perspectives: diagnosis and treatment of tuberculosis Year: 2007 Genetic polymorphism and phenotypic resistance of Mycobacterium tuberculosis to fluoroquinolones of different generations Source: Virtual Congress 2021 – Advances in the diagnosis of tuberculosis, multidrug-resistant tuberculosis and nontuberculous mycobacterial disease Year: 2021 Design of immunogenic multiepitopic mycobacterium tuberculosis peptides from genes selected using in vitro models of mycobacterial macrophage infection Source: Eur Respir J 2007; 30: Suppl. 51, 493s Year: 2007 Study of genetic heterogeneity in Mycobacterium tuberculosis isolates from tuberculosis patients using DNA fingerprinting Source: Eur Respir J 2005; 26: Suppl. 49, 655s Year: 2005 Clinical and laboratory features of Mycobacterium avium complex infection in comparison with infection, caused by Mycobacterium tuberculosis, in HIV-infected patients Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II Year: 2019